Analyst
J.P. Morgan
Equibles does not estimate personal net worth.
Marcus Robert is recorded as Analyst at J.P. Morgan. Marcus Robert has spoken on 5 earnings calls across 5 companies, most recently for Heartflow, Inc. on August 13, 2026. Those appearances were for Heartflow, Inc. (HTFL), Intuitive Surgical Inc (ISRG), Abbott Laboratories (ABT), RxSight, Inc. (RXST) and Baxter International Inc (BAX). The companies whose calls Marcus Robert spoke on are classified in the Healthcare sector.
“And congratulations on a great quarter here. Two for me. Maybe first, you talk about this a little bit in the prepared remarks, but you're doing a phenomenal job driving adoption in FLAC.”
“So, one for me, the CapEx environment is one of the most important catalysts and background items for intuitive. There is obviously concern amongst investors as bad debt might build at hospitals as people fall off ACA and Medicaid.”
“We heard from you this morning, particularly on the diagnostic volumes where you have a great view into forward-looking volumes. You know, it sounds like you're not seeing anything.”
“It was good to see that you were able to kind of find footing and deliver a modest beat against consensus here.”
“Andrew, you've been there for... two months, almost two months, making some pretty important and bold moves on capital allocation.”
J.P. Morgan
Analyst
Transcript header (unverified)
HTFL
Health Information Services · Healthcare
Medical Instruments & Supplies · Healthcare
RXST
Medical Devices · Healthcare
Medical Instruments & Supplies · Healthcare
